It’s important to stay well-informed when it comes to neurological diseases and disorders, not only for those inflicted but also for their families, caregivers, and friends. While the internet provides us with a wealth of knowledge, oftentimes it can be difficult to decipher whether or not certain information is trustworthy.
Last month, at a Capitol Hill briefing in Washington, D.C., experts gathered to address the surge in opioid drug abuse and fatal overdoses among people of all demographics within the United States. According to a 2010 study done by the Centers for Disease Control, prescription opioids accounted for 60% of overdose deaths, a statistic that has doubled in just over ten years. While there is work being done by federal and state agencies to deter future abuse of prescription painkillers, speakers of the event focused particularly on those who are imprisoned as a result of their addiction.
Guest post by Barbara Sahakian, FMedSci, DSc, a professor in the department of psychiatry at the University of Cambridge, and president of the International Neuroethics Society.
More than half of all prison and jail inmates have a mental health problem.[i] In addition, according to a 2010 report released by the Treatment Advocacy Center and the National Sheriffs’ Association,[ii] more mentally ill persons are in jails and prisons than in hospitals, and many of those remain untreated. Those in prison have a higher risk of substance abuse, and suicide rates are four to five times higher than within the general population.[iii] Deaths are also increased upon release, with the most common reasons being drug overdose, cardiovascular disease, homicide, and suicide.[iv]
Below is yesterday’s Dana News email blast. You can sign up to receive this (and other Dana email alerts and/or print publications) by going here.
In July 2014, an international consortium of schizophrenia researchers mounted the largest biological experiment in the history of psychiatry. Now, with many more avenues for exploring the biological underpinnings of schizophrenia available to neuroscientists, hope may be on the way for the estimated 1 in 100 people worldwide affected by the illness. From Cerebrum, our online magazine of ideas. Also check out a Q&A with Dr. Sullivan.